Tumor-Associated Vasculature

Known as: Neovasculature 
New blood vessels formed by solid tumors.
National Institutes of Health

Related topics

Related topics

2 relations
CD248 protein, humanglutamate carboxypeptidase II, human

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2013
Highly Cited
2013
Oncolytic vaccinia virus disrupts tumor-associated vasculature in humans.
Efforts to selectively target and disrupt established tumor vasculature have largely failed to date. We hypothesized that a… (More)
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Highly Cited
2011
Highly Cited
2011
Targeting tumor vasculature with an oncolytic virus.
Oncolytic viruses (OVs) have been engineered or selected for cancer cell-specific infection however, we have found that following… (More)
Is this relevant?
Highly Cited
2007
Highly Cited
2007
CXCR7 (RDC1) promotes breast and lung tumor growth in vivo and is expressed on tumor-associated vasculature.
Chemokines and chemokine receptors have been posited to have important roles in several common malignancies, including breast and… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Highly Cited
2006
Highly Cited
2006
B7-H4 expression in renal cell carcinoma and tumor vasculature: associations with cancer progression and survival.
B7-H4 is a recently described B7 family coregulatory ligand that has been implicated as an inhibitor of T cell-mediated immunity… (More)
Is this relevant?
Highly Cited
2004
Highly Cited
2004
Cancer siRNA therapy by tumor selective delivery with ligand-targeted sterically stabilized nanoparticle.
Potent sequence selective gene inhibition by siRNA 'targeted' therapeutics promises the ultimate level of specificity, but siRNA… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
2000
Highly Cited
2000
Heterogeneity of angiogenesis and blood vessel maturation in human tumors: implications for antiangiogenic tumor therapies.
Microvessel density (MVD) counting techniques have been widely used to assess the vasculature in tumors. MVD counts assess the… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
1999
Highly Cited
1999
In vivo imaging of tumors with protease-activated near-infrared fluorescent probes
We have developed a method to image tumor-associated lysosomal protease activity in a xenograft mouse model in vivo using… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • table 1
Is this relevant?
Highly Cited
1999
Highly Cited
1999
Five different anti-prostate-specific membrane antigen (PSMA) antibodies confirm PSMA expression in tumor-associated neovasculature.
Prostate-specific membrane antigen (PSMA) is a type II integral membrane glycoprotein that was initially characterized by the… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • table 2
Is this relevant?
Highly Cited
1999
Highly Cited
1999
Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization.
Circulating endothelial progenitor cells (EPCs) have been isolated in peripheral blood of adult species. To determine the origin… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Highly Cited
1996
Highly Cited
1996
Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells
Inadequate presentation of tumor antigens by host professional antigen–presenting cells (APCs), including dendritic cells (DCs… (More)
Is this relevant?